Scientific Games Corporation SGMS reported a loss of $1.23 per share for third-quarter 2020. The company had reported earnings of 15 cents per share in the year-ago quarter.
Revenues came in at $698 million, down 18.4% year over year. The decline primarily resulted from decline in Gaming revenues due to continued reduced operations of casino operators globally as a result of coronavirus-led business disruptions.
Notably, the Zacks Consensus Estimate for earnings and revenues was pegged at loss of 76 cents per share and $663 million, respectively.
Services revenues decreased 7.7% to $417 million. Product sales were down 51.4% to $124 million. Meanwhile, Instant product revenues came in at $157 million, up 6.1%.
Scientific Games Corp Price, Consensus and EPS Surprise
Scientific Games Corp price-consensus-eps-surprise-chart | Scientific Games Corp Quote
Gaming revenues (33.1% of revenues) decreased 49.1% year over year to $231 million. The company’s Gaming revenues were negatively impacted by COVID-19 disruptions that resulted in continued reduced operations of casino operators in various jurisdictions globally.
Notably, as of Nov 4, 90% of domestic casinos have reopened including New York commercial casinos (a large market that opened in mid-September).
Meanwhile, Lottery revenues (34.5% of revenues) increased 9.5% year over year to $241 million driven by domestic instant tickets and international product sales.
During the quarter, Scientific Games announced their latest lottery entertainment innovations with the new 7-11-21 LIVE! game, available to state lotteries in the United States.
Markedly, Lottery instant ticket sales are up over 20% for instant game retail sales in the most recent twelve-week period compared to the same period last year. During the quarter, the company launched its first advanced lottery self-service instant ticket vending technology with PlayCentral HD in Sachsenlotto Lottery located in Saxony, Germany.
SciPlay revenues (21.6% of revenues) climbed 30.2% year over year to $151 million driven by increased game health, attributable to game updates and features implemented during the quarter to maximize player engagement and the stay-at-home dynamic related to COVID-19.
Moreover, average revenue per daily active user (ARPDAU) increased 34% to 63 cents. Moreover, SciPlay mobile penetration increased 300 basis points (bps) to 87%.
Digital (10.7% of revenues) revenues rose 15.4% year over year to $75 million. Domestic iGaming revenues grew nearly 150% year over year driven primarily by strong growth in New Jersey.
During the quarter, Scientific Games announced new and extended partnerships with Hard Rock, Flutter and Wynn Resorts among others.
Consolidated adjusted EBITDA (AEBITDA) decreased 31.7% year over year to $235 million. AEBITDA margin, as a percentage of revenues, contracted 660 bps to 33.7% in the reported quarter.
Gaming AEBITDA decreased 65.9% year over year to $77 million while Lottery AEBITDA increased 10.1% from the year-ago quarter to $109 million. Further, Lottery AEBITDA margin expanded 400 basis points (bps) to 15.6%.
SciPlay AEBITDA surged 53.1% to $49 million. In addition, AEBITDA margin expanded 330 bps to 7%.
Further, Digital AEBITDA rose 47.1% from the year-ago quarter to $25 million. Digital AEBITDA margin expanded 160 bps to 3.6%.
Selling, general and administrative expenses decreased 3.6% year over year to $164 million. Moreover, research & development expenses declined 12.8% to $41 million.
Balance Sheet & Cash Flow
As of Sep 30, cash and cash equivalents were $1.04 billion compared with $790 million as of Jun 30, 2020.
Net debt was $8.47 billion as of Sep 30 compared with $8.52 billion as of Jun 30.
As of Sep 30, the company had $1.2 billion in available liquidity, which included SciPlay’s revolving credit facility.
On Oct 8, the company amended its credit agreement that extended the Covenant Relief Period under its revolving credit facility through the first quarter of 2022 and made a $100 million voluntary payment.
Net debt leverage ratio was 9.6 times as of Sep 30. Scientific Games aims at achieving net debt leverage of 6 times by the end of 2020 and 5.5 times in 2021.
Cash from operating activities was $140 million compared with the prior quarter’s $52 million. Free cash flow was $62 million compared with $5 million in the previous quarter.
For 2020, the company now anticipates capital expenditure in the range of $210 million-$225 million.
Key Development in Q3
Scientific Games announced that a number of long-term institutional investors — including gaming industry investor Caledonia — have reached an agreement to acquire a 34.9% stake in Scientific Games from MacAndrews & Forbes Incorporated at a price of $28.00 per share.
Zacks Rank & Stocks to Consider
Scientific Games currently carries a Zacks Rank #3 (Hold).
Himax Technologies HIMX, NVIDIA NVDA, and Covetrus CVET are some better-ranked stocks in the broader computer and technology sector. Each carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks Rank #1 (Strong Buy) stocks here.
Covetrus, Hiamx Technologies and NVIDIA will report third-quarter 2020 results on Nov 10, Nov 12 and Nov 18, respectively.
These Stocks Are Poised to Soar Past the Pandemic
The COVID-19 outbreak has shifted consumer behavior dramatically, and a handful of high-tech companies have stepped up to keep America running. Right now, investors in these companies have a shot at serious profits. For example, Zoom jumped 108.5% in less than 4 months while most other stocks were sinking.
Our research shows that 5 cutting-edge stocks could skyrocket from the exponential increase in demand for “stay at home” technologies. This could be one of the biggest buying opportunities of this decade, especially for those who get in early.
See the 5 high-tech stocks now>>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
NVIDIA Corporation (NVDA) : Free Stock Analysis Report
Scientific Games Corp (SGMS) : Free Stock Analysis Report
Himax Technologies, Inc. (HIMX) : Free Stock Analysis Report
Covetrus, Inc. (CVET) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research